GregoryDLewisMD
Cardiology • Boston, MAHeart Failure & Transplantation
Section Head, Heart Failure Medical Director of Heart Transplantation Director, CPET Laboratory Massachusetts General Hospital
Dr. Lewis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
GRB 800
Boston, MA 02114Phone+1 617-724-9254Fax+1 617-726-4105
Education & Training
Massachusetts General HospitalResidency, Internal Medicine, 1999 - 2002
University of Rochester School of Medicine and DentistryClass of 1999
Certifications & Licensure
MA State Medical License 2001 - 2026
NH State Medical License 2024 - 2024- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
Clinical Trials
- Validation of Electrical Cardiometry Versus Fick Method in Cardiac Output Measurement Start of enrollment: 2012 Mar 01
- Study to Evaluate Effect of Nebivolol on Angina in Women With Microvascular Disease Start of enrollment: 2013 Apr 01
- Gas Exchange for Predicting Hospital Heart Failure Readmissions Start of enrollment: 2013 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 297 citationsThe SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.Michael E. Nassif, Sheryl L. Windsor, Barry A. Borlaug, Dalane W. Kitzman, Sanjiv J. Shah
Nature Medicine. 2021-10-28 - 16 citationsExercise Capacity in Patients With Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM Baseline Characteristics and Study Design.Caroline J Coats, Martin S Maron, Theodore P Abraham, Iacopo Olivotto, Matthew M Y Lee
JACC. Heart Failure. 2024-01-01 - 870 citationsEffect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: A randomized clinical trialMargaret M. Redfield, Horng H. Chen, Barry A. Borlaug, Marc J. Semigran, Kerry L. Lee
JAMA. 2013-03-27
Journal Articles
- Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients with Heart Failure with Preserved Ejection FractionGregory D Lewis, David J Whellan, Martin M LeWinter, Margaret M Redfield, Andrew L Smith, Eugene Braunwald, Michael M Givertz, Adrian F Hernandez, Sanjiv J Shah, Horng..., JAMA
- The Effect of Donor Age on Post‐Transplant Mortality in a Cohort of Adult Cardiac Transplant Recipients Aged 18 to 45Gregory D Lewis, Amy G Fiedler, Heidi Yeh, American journal of transplantation
- Heart Failure with Preserved Ejection Fraction Expert Panel ReportKishan S Parikh, Howard K Surks, Sanjiv J Shah, Marvin A Konstam, Margaret M Redfield, Robert M Califf, Kavita Sharma, Narimon Honarpour, Gregory D Lewis, Scott D Solo..., ScienceDirect
- Join now to see all
Press Mentions
Heart Drug Improved Exercise Tolerance in Clinical Trial of Patients with Hypertrophic Obstructive CardiomyopathySeptember 4th, 2024- Omecamtiv Mecarbil Fails to Improve Exercise Capacity in HFrEFAugust 5th, 2022
- Short Bursts of Exercise Boost Markers of Good HealthJanuary 13th, 2021
- Join now to see all
Grant Support
- Iron Homeostasis in Heart FailureNIH2020–2024
- Metabolic Profiling of ExerciseNIH2016–2020
- Metabolic Profiling Of Acute Myocardial Injury In HumansNational Heart, Lung, And Blood Institute2008–2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
